Hyungjin Cho
LG Chem · LG Chem, Ltd.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hyungjin Cho as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:35 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05586971 · Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout PatientsLG Chem · completed · Gout, Hyperuricemia, Gout Flare · study director
- Ph3NCT05586958 · Tigulixostat, Phase 3 Study, Placebo Controlled in Gout PatientsLG Chem · completed · Gout, Hyperuricemia, Gout Flare · study director
- Ph2NCT03934099 · A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With HyperuricemiaLG Chem · completed · Gout, Hyperuricemia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:35 UTC. The ranking covers the 200 most relevant of 447 PubMed records, and a shared surname and initials can bring in a namesake. All 447 on PubMed
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.Nature · 20101,437 citationsRCR 31.5
- 348 citationsRCR 13.2
- Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.Cancer Discov · 2021203 citationsRCR 8.7
- 156 citationsRCR 19.7
- 100 citationsRCR 6.3
- Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.Br J Cancer · 201789 citationsRCR 4.1
- A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer.Clin Cancer Res · 199988 citationsRCR 2.1
- Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer.Br J Surg · 201783 citationsRCR 3.9
- Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study.J Korean Med Sci · 200879 citationsRCR 2.5
- Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer.Clin Cancer Res · 202174 citationsRCR 3.5